期刊文献+

奥曲肽用于肠梗阻非手术治疗的临床疗效分析 被引量:2

To Explore Clinical Effect on Octreotide for Intestinal Obstruction of Non-operative Treatment
下载PDF
导出
摘要 目的:分析奥曲肽用于肠梗阻非手术治疗的临床疗效。方法选取于2013年2月~2014年12月期间的我院胃肠科60例肠梗阻非手术治疗患者,将其随机分为对照组(n=26)和治疗组(n=34),对照组给予常规的保守治疗,治疗组在对照组的基础上联合奥曲肽治疗,比较两组患者的临床疗效。结果治疗组的总有效率高于对照组,治疗组的肛门排气时间和平均住院时间均短于对照组,P<0.05,差异具有统计学意义。结论奥曲肽用于肠梗阻非手术治疗能提高总有效率,减少患者肛门排气时间和平均住院时间。 Objective To explore clinical effect on octreotide for intestinal obstruction of non-operative treatment . Methods Selected 60 patients with intestinal obstruction non-operative therapy from February 2013 to December 2013 in our hospital gastrointestinal department, divided into the control group (n=26) and the treatment group (n=34) randomly, the control group given conservative treatment, the treatment group in the control group on the basis of the octreotide treatment, compared the clinical effect of two groups. Results The treatment group total effective rate was higher than the control group,the treatment group of anal exhaust time and the average length of hospital stay were shorter than the control group, P〈0.05,had difference statistically significance. Conclusion Octreotide for intestinal obstruction non-surgical treatment can improve the total effective rate, anal exhaust time and the average length of hospital stay, reduce patients have clinical application value.
作者 刘芬
出处 《中国继续医学教育》 2015年第13期159-160,共2页 China Continuing Medical Education
关键词 奥曲肽 肠梗阻非手术治疗 临床疗效 Octreotide Intestinal obstruction non-surgical treatment Clinical curative effect
  • 相关文献

参考文献6

二级参考文献35

  • 1汪鸿志.上消化道出血的诊断与治疗[J].新医学,2006,37(12):814-816. 被引量:42
  • 2Mercadant e S,Ripamonti C,Casuccio A,et al.Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction[J].Supportive Care in Cancer 2000, 8(3): 188- 191. 被引量:1
  • 3Kutun S Ulucanlar H,Celik A,et al. Effects of octreotide on healing of mechanical ileus in rats[J].Saudf Med J, 2008,29(4),539-543. 被引量:1
  • 4Pamonti C,Twycross R,Baines M,et al.Clinical-practice recommendations for the management of bowel obstruction in patients with end--stage cancer[J]. Support Care Cancer,2001,9:223-233. 被引量:1
  • 5Cascini GL,Cuccurullo V,Mansi L.The non tumour uptake of 111Inoctreotide creates new clinical indications in benign disease, but also in oncology[J].Q J Nucl Med Mol Imaging,2010 Feb,54(1):24-36. 被引量:1
  • 6Krouse RS. Surgical palliation of bowel obstruction [J]. Gastroenterol Clin North Am, 2006,35:143-151. 被引量:1
  • 7Mercadante S, Casuccio A, Mangione S. Medical treatment for inop- erable malignant bowel obstruction: a qualitative systematic review.J Pain Symptom Manage, 2007; 33: 217-223. 被引量:1
  • 8Khoo D, Hall E, Motson R, et al. Palliation of malignant intestinal ob- struction using octreotide. Eur J Cancer,1994,30A:28-30. 被引量:1
  • 9Mystakidou K, Tsilika E, Kalaidopoulou O, et al.Comparison of oc- treotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized,double-blind, controlled clinical trial. Anticancer Res, 2002, 22: 1187-1192. 被引量:1
  • 10Mangili G, Franchi M, Mariani A, et al. Octreotide in the management of bowel obstruction in terminal ovarian cancer. Gynecol Oncol, 1996, 61: 345-348. 被引量:1

共引文献57

同被引文献9

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部